Beam Funding: $170M Raised, Investors & Rounds

Beam is a Biotech company based in United States. It has raised $170M in total funding. Backed by Mercato Partners, Traverse, Drive Capital.

Beam funding overview

Beam is a Biotech company based in United States. Beam has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Investors on record include Mercato Partners, Traverse, Drive Capital, Georgian, Nationwide, Breakout Capital. 6 distinct backers are named across the disclosed rounds.

Beam at a glance

Total raised
$170M
Industry
Biotech
Headquarters
United States
Notable investors
Mercato Partners, Traverse, Drive Capital, Georgian, Nationwide, Breakout Capital

Frequently asked about Beam funding

How much has Beam raised?
Beam has raised $170M in total disclosed funding across the rounds on record.
Who has invested in Beam?
Mercato Partners, Traverse, Drive Capital, Georgian, Nationwide, Breakout Capital are named among the investors backing Beam.
What was the latest Beam funding round?
No round stage has been disclosed for Beam.
Where is Beam based?
Beam is based in United States.
What sector does Beam operate in?
Beam is tracked under Biotech from United States, with $170M in disclosed funding.

Round data for Beam is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in United States and backer lists below.

Beam pitch deck

The investor deck Beam used to raise — 2021, Series E, 14-slide deck is broken down slide by slide, including the slides it leads with and the questions it leaves open.

Beam founders (2)

Companies related to Beam (40)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026